2129 N Congress Ave, Riviera Beach, FL 33404 [email protected] 561.847.2302

Sancilio Pharmaceuticals Company to Present New Research on Altemia™ to Treat Sickle Cell Disease at the ASPHO Conference

RIVIERA BEACH, Fla. – April 30th, 2018 – Sancilio Pharmaceuticals Company, Inc (SPCI) will present new research data from the Phase 2 study (SCOT trial) on SC411 (Altemia™) at the 2108 American Society Pediatric Hematology and Oncology (ASPHO)… Read More

Altemia™ Achieves Successful Clinical Results in Pediatric Patients with Sickle Cell Disease (SCD)

RIVIERA BEACH, Fla. – November 1st, 2017 Statistically significant results confirm the mechanism of action of AltemiaTM for the treatment of SCD Primary and secondary endpoints were met A clinically meaningful reduction of vaso-occlusive crises (VOCs) was observed… Read More

Sancilio Pharmaceuticals Company, Inc. to Present an Update on Research in Sickle Cell at Upcoming National SCDAA Convention

RIVIERA BEACH, Florida. – October 26th, 2017 Sancilio Pharmaceuticals Company, Inc. (SPCI) will present an update on the research program in the field of sickle cell disease, at the National Sickle Cell Disease Association of America (SCDAA) convention,… Read More